학회

제9회 단편 기반 신약 개발 회의

달력날짜 및 시간
  • 2024년 3월 3일~5일
위치위치
  • 영국 케임브리지

Schrödinger 는 3월 3일부터 5일까지 영국 케임브리지의 힌스톤 홀(Hinxton Hall)에서 열리는제9회 단편 기반 신약 개발 회의(9th Fragment-based Drug Discovery Meeting )에 참가하게 되어 기쁘게 생각합니다. Schrödinger 의 수석 연구원 I인 안토니야 쿠즈마니치(Antonija Kuzmanic)가 발표하는 “절대 자유 에너지 섭동(AB-FEP+)을 기반으로 한 대규모 컴퓨터 시뮬레이션 단편 스크리닝”이라는 제목의 포스터 발표에 많은 관심 부탁드립니다.

Title: Large-scale in silico Fragment Screening Based on Absolute Free Energy Perturbation (AB-FEP+)
Speaker:
Antonija Kuzmanic, Principal Scientist I
Abstract:
Fragment screening has witnessed remarkable success with 6 FDA approved drugs and many more in clinical trials. Here we present a computational innovation to dramatically expand the scope of fragment screening, from screening typical ~3k – 30k experimental fragment libraries to screening ~200 million fragments with high hit rates. This approach involves a virtual screening funnel based on Absolute Free Energy Perturbation to rigorously score diverse fragments based on their predicted binding affinities, allowing for only a small number of fragments (~25-50) to be purchased and/or synthesized for experimental testing. This approach has already been successfully applied during the hit finding stage for several active internal drug discovery projects, resulting in potent (nM – uM), ligand efficient (LE 0.38 – 0.51) starting points from which to initiate our discovery campaigns. In the TPL2 project, five fragments hits (<100 uM) were identified from fragment screening and were expanded to develop initial SAR, which led to discovery of the hit compounds.